title: SCAI expert consensus statement: Evaluation, management, and special considerations of cardio-oncology patients in the cardiac catheterization laboratory (Endorsed by the Cardiological Society of India, and Sociedad Latino Americana de Cardiologıa Intervencionista).
abstract: In the United States alone, there are currently approximately 14.5 million cancer survivors, and this number is expected to increase to 20 million by 2020. Cancer therapies can cause significant injury to the vasculature, resulting in angina, acute coronary syndromes (ACS), stroke, critical limb ischemia, arrhythmias, and heart failure, independently from the direct myocardial or pericardial damage from the malignancy itself. Consequently, the need for invasive evaluation and management in the cardiac catheterization laboratory (CCL) for such patients has been increasing. In recognition of the need for a document on special considerations for cancer patients in the CCL, the Society for Cardiovascular Angiography and Interventions (SCAI) commissioned a consensus group to provide recommendations based on the published medical literature and on the expertise of operators with accumulated experience in the cardiac catheterization of cancer patients.
authors.affiliation: University of Texas, MD Anderson Cancer Center, Houston, Texas.
authors.forename: Cezar
authors.initials: C
authors.lastname: Iliescu
authors.affiliation: Detroit Medical Center, Cardiovascular Institute, Detroit, Michigan.
authors.forename: Cindy L
authors.initials: CL
authors.lastname: Grines
authors.affiliation: Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
authors.forename: Joerg
authors.initials: J
authors.lastname: Herrmann
authors.affiliation: Division of Cardiology, University of California at Los Angeles, Los Angeles, California.
authors.forename: Eric H
authors.initials: EH
authors.lastname: Yang
authors.affiliation: School of Medicine, Arkansas Heart Hospital, Little Rock, Arkansas.|Koc University, Istanbul, Turkey.
authors.forename: Mehmet
authors.initials: M
authors.lastname: Cilingiroglu
authors.affiliation: University of Texas Health Science Center, Houston, Texas.
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Charitakis
authors.affiliation: University of Arkansas for Medical Sciences, Little Rock, Arkansas.
authors.forename: Abdul
authors.initials: A
authors.lastname: Hakeem
authors.affiliation: Hippokration General Hospital, Athens Medical School, Athens, Greece.
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Toutouzas
authors.affiliation: University of Alabama at Birmingham, Birmingham, Alabama.
authors.forename: Massoud A
authors.initials: MA
authors.lastname: Leesar
authors.affiliation: Citizens Memorial Hospital, Bolivar, Missouri.|University of Missouri, Columbia, Missouri.
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Marmagkiolis
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D006328:Cardiac Catheterization / Q000009:adverse effects / Q000592:standards*; D002309:Cardiology / Q000592:standards*; D066126:Cardiotoxicity; D032921:Consensus; D017023:Coronary Angiography / Q000009:adverse effects / Q000592:standards*; D006331:Heart Diseases / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy*; D006801:Humans; D008495:Medical Oncology / Q000592:standards*; D009369:Neoplasms / Q000150:complications / Q000628:therapy*; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects / Q000592:standards*; D011237:Predictive Value of Tests; D011832:Radiation Injuries / Q000000981:diagnostic imaging / Q000209:etiology / Q000628:therapy*; D011878:Radiotherapy / Q000009:adverse effects; D012307:Risk Factors; D017741:Survivors; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents
keywords: catheterization; complex PCI; diagnostic; percutaneous coronary intervention; right heart catheterization; stent restenosis; stent thrombosis